CPhI North America is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.
Robert C. McCarthy, Ph.D., is President of VitaCyte LLC (www.vitacyte.com), a firm he co-founded with Francis Dwulet in 2003. Bob and Francis were key members of the project team at Boehringer Mannheim Biochemicals that developed the first purified collagenase-neutral protease enzyme mixture used to recover human islets from donor pancreata. Liberase™ HI Purified Enzyme Blend increased human islet yields that contributed to the success of the “Edmonton Protocol,” the first successful use of human islet transplantation to manage adult type I diabetic patients. VitaCyte continues to be in the forefront to generate knowledge that is applicable to the therapeutic applications of these enzymes. Clostridium histolyticum collagenase is used as an ancillary reagent to isolate therapeutic cells or as a biotherapeutic active pharmaceutical ingredient.